Connecting impairment, disability, and handicap in immune mediated polyneuropathies

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 1, 2003, Pages 99-104

  Merkies, I S J ^a   Schmitz, P I M ^a   Van der Meche F G A ^a   Samijn, J P A ^a   Van Doorn, P A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CORRELATION ANALYSIS; DEVICE; DISABILITY; FEMALE; GAMMOPATHY; GRIP STRENGTH; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTIVE THRESHOLD; PHYSICAL DISABILITY; POLYNEUROPATHY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; WALKING;

EID: 0037226919     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.1.99     Document Type: Article

References (30)

1. World Health Organisation. International Classification of Impairments, Disabilities, and Handicaps. Geneva: WHO, 1980.
2. Harwood RH, Prince M, Mann A, et al. Associations between diagnosis, impairments, disability and handicap in a population of elderly people. Int J Epidemiol 1998;27:261-8.
3. Coulthard-Morris L, Burks JS, Herndon RM. Rehabilitation outcome measures. In: Herndon RM, ed. Handbook of Neurologic Rating Scales. New York: Demos Vermande, 1997:225-64.
4. Wade DT. Measurements in Neurological Rehabilitation. Oxford: Oxford University Press, 1992.
5. Cowley AJ, Fullwood LJ, Muller AF, et al. Exercise capability in heart failure: Is cardiac output important after all? Lancet 1991;337:771-3.
6. Williams SJ, Bury MR. "Breathtaking": The consequences of chronic respiratory disorder. Int Disabil Stud 1989;11:114-20.
7. Merkies ISJ, Schmitz PIM, Samijn JP, et al, for the Inflammatory Neuropathy Cause and Treatment (INCAT) group. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve 2000;23:1393-401.
8. Hartung H-P, van der Meché FGA, Pollard JD. Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies. Curr Opin Neurol 1998;11:497-513.
9. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-4.
10. Ad Hoc Subcommittee. American Academy of Neurology AIDS task force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-18.
11. Miescher GC, Steck AJ. Paraproteinaemic neuropathies. Baillieres Clin Neurol 1996;5:219-32.
12. Kleyweg RP, van der Meché FGA, Schmitz PIM. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991;14:1103-9.
13. Merkies ISJ, Schmitz PIM, van der Meché FGA, et al, for the Inflammatory Neuropathy Cause and Treatment (INCAT) group. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology 2000;54:943-7.
14. Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
15. Merkies ISJ, Schmitz PIM, Samijn JPA, et al, for the European Inflammatory Neuropathy Cause and Treatment (INCAT) group. Fatigue in immune-mediated polyneuropathies. Neurology 1999;53:1648-54.
16. Merkies ISJ, Schmitz PIM, van der Meché FGA, et al, for the Inflammatory Neuropathy Couse and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72:596-601.
17. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
18. Mathiowetz V, Weber K, Kashman N, et al. Adult norms for the nine hole peg test of finger dexterity. Occup Ther J Res 1985;5:24-38.
19. Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: Reliability of measures of impairment and disability. Int Disab Stud 1990;12:6-9.
20. Merkies ISJ, Schmitz PIM, van der Meché FGA, et al, for the Inflammatory Neuropathy Cause and Treatment (INCAT) group. Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies. Muscle Nerve 2002;25:370-7.
21. American Society of Hand Therapists. Clinical Assessment Recommendations, 2nd Ed. Chicago: ASHT, 1992.
22. Herndon JE, Harrell FE. The restricted cubic spline hazard model. Comm Stat Theory Methods 1990;19:639-63.
23. Hobart JC, Lamping DL, Thompson AJ. Evaluating neurological outcome measures: The bare essentials. J Neurol Neurosurg Psychiatry 1996;60:127-30.
24. Molenaar DS, Vermeulen M, de Visser M, et al. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies. Neurology 1999;52:151-6.
25. Lennon SM, Koblar S, Hughes RAC, et al. Reasons for persistent disability in Guillain-Barré syndrome. Clin Rehabil 1993;7:1-8.
26. Bernsen RAJAM, de Jager AEJ, Schmitz PIM, et al. Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome. Neurology 1999;53:409-10.
27. Nicholas R, Playford ED, Thompson AJ. A retrospective analysis of outcome in severe Guillain-Barré syndrome following combined neurological and rehabilitation management. Disabil Rehabil 2000;22:451-5.
28. Pitetti KH, Barrett PJ, Abbas D. Endurance exercise training in Guillain-Barré syndrome. Arch Phys Med Rehabil 1993;74:761-5.
29. de Jager AEJ, Minderhoud JM. Residual signs in severe Guillain-Barré syndrome: Analysis of 57 patients. J Neurol Sci 1991;104:151-6.
30. World Health Organisation. International Classification of Functioning, Disability and Health. Geneva: WHO, 2001.